SARS‐CoV‐2 replicating in nonprimate mammalian cells probably have critical advantages for COVID‐19 vaccines due to anti‐Gal antibodies: A minireview and proposals-Reference-Cited by-同舟云学术

SARS‐CoV‐2 replicating in nonprimate mammalian cells probably have critical advantages for COVID‐19 vaccines due to anti‐Gal antibodies: A minireview and proposals

Published:2020-08-02 Issue:1 Volume:93 Page:351-356
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Chen Ji‐Ming¹²^ORCID

Affiliation:

1. College of Veterinary Medicine Qingdao Agricultural University Qingdao China

2. Qingdao Six‐Eight Nearby Sci‐Tech Company Qingdao China

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.26312

Reference49 articles.

1. World Health Organization. Coronavirus disease (COVID‐2019) situation reports.https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed July 13 2020.

2. The Center for Systems Science and Engineering at Johns Hopkins University. COVID‐19 dashboard.https://coronavirus.jhu.edu/map.html. Accessed July 13 2020.

3. Preventive and treatment strategies of COVID-19: From community to clinical trials

4. The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world

5. Progress and Prospects on Vaccine Development against SARS-CoV-2

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine;Biomaterials Research;2023-02-09

2. Antibody isotype epitope mapping of SARS‐CoV‐2 Spike RBD protein: Targets for COVID‐19 symptomatology and disease control;European Journal of Immunology;2023-02

3. Approaching Challenges Posed by SARS-CoV-2 Genetic Variants;Pathogens;2022-11-23

4. The Meat of the Matter: Understanding and Managing Alpha-Gal Syndrome;ImmunoTargets and Therapy;2022-09

5. Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein;Frontiers in Bioengineering and Biotechnology;2021-08-16